The University of Texas MD Anderson Cancer Center

Institute Associate Scientist II - Neurodegeneration Consort

MD Anderson Cancer Center

Houston, TX, United States

MD ANDERSON THERAPEUTICS DISCOVERY DIVISION Within The University of Texas MD Anderson Cancer Center lies a powerful engine driving the future of new targeted, immune- and cell-based therapies: the Therapeutics Discovery Division. Therapeutics Discovery eliminates the bottlenecks that hamper traditional drug discovery, with a multidisciplinary team of dedicated researchers, doctors, drug developers and scientific experts working together to develop small-molecule drugs, biologics and cellular therapies. Our unique structure and collaborative approach allow the team to work with agility, bringing novel medicines from concept to clinic quickly and efficiently – all under the same roof. The Therapeutics Discovery Division is built around four platforms: The Institute for Applied Cancer Science (IACS), ORBIT (Oncology Research for Biologics and Immunotherapy Translation), TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology) and the Neurodegeneration Consortium (NDC). The NDC is a multi-institutional initiative launched to better understand the biology of neurodegenerative diseases and translate that knowledge into effective therapeutics interventions. Established in 2012 by a gift from the Robert A. and Renee E. Belfer Family Foundation, the NDC brings researchers from Baylor College of Medicine, the Massachusetts Institute of Technology and the Icahn School of Medicine at Mount Sinai together with drug discovery and development experts from MD Anderson's Therapeutics Discovery division. The mission of the NDC is to develop new medicines that will lead to a cure for Alzheimer's disease, but also to treat a variety of neurodegenerative conditions, including the neural and cognitive impairments that commonly result in cancer patients as a result of their treatment. The Institute Assistant Scientist II participates in cross-functional research to validate novel targets for neurodegenerative diseases, and translate these finding into novel therapeutic agents to benefit patients. An ideal candidate will be able to work in an interdisciplinary team to support our internal drug discovery efforts as well as to participate in developing novel approaches to optimize and increase throughput of drug discovery projects. By joining the Therapeutics Discovery Division, you have the opportunity to use your talents to make a direct impact on the lives of our patients. We are seeking a highly motivated and collaborative individual to become a part of our team. JOB SPECIFIC COMPETENCIES • Under moderate supervision, plan and execute laboratory experiments using a broad range of biochemistry, molecular and cellular techniques including but not limited to: immunofluorescence, immunohistochemistry, western blotting, shRNA, flow cytometry, high-throughput imaging and microscopy • Work collaboratively with the NDC team members to support multiple projects aimed at validating novel targets, developing new assays and supporting the NDC drug discovery programs • Document experiments in electronic lab notebook • Employ safe laboratory practice • Communicate results through written and oral presentations Education Required: Bachelor's degree in Biology, Biochemistry, Molecular Biology, Cell Biology, Enzymology, Pharmacology, Chemistry or related field. Preferred: Master's degree in Neuroscience, Pharmacology or Biology. Experience Required: One year of relevant research experience in lab. With preferred degree, no required experience. Preferred: Demonstrated experience in cell culture and/or immunostaining and Biochemistry techniques. The position requires a highly self-motivated individual, with outstanding organizational skills, the ability to learn to effectively present results and conclusions to co-workers, collaborators and manager. Ability to multitask, work well under pressure and drive personal and team objectives that impact critical timelines is expected. A collaborative attitude is essential for this position. It is the policy of The University of Texas MD Anderson Cancer Center to provide equal employment opportunity without regard to race, color, religion, age, national origin, sex, gender, sexual orientation, gender identity/expression, disability, protected veteran status, genetic information, or any other basis protected by institutional policy or by federal, state or local laws unless such distinction is required by law. SONJ Additional Information Requisition ID: 127061 Employment Status: Full-Time Employee Status: Regular FLSA: exempt and not eligible for overtime pay Work Week: Days Fund Type: Soft Pivotal Position: Yes Minimum Salary: US Dollar (USD) 48,000 Midpoint Salary: US Dollar (USD) 67,000 Maximum Salary : US Dollar (USD) 86,000

Please apply via recruiter’s website.

Quote Reference: MD Anderson-md_anderson-4432_127061